ACCEPTANCE OF AND DISCONTINUATION RATE FROM PAROXETINE TREATMENT IN PATIENTS WITH LIFELONG PREMATURE EJACULATION: AN OBSERVATIONAL SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE